{"entity":{"type":"insider","cik":"0001869579","url":"/insider/0001869579","json_url":"/insider/0001869579.json","name":"Imran Talat","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":7,"first":"2023-11-09","last":"2026-07-21","span_basis":"filed_date"},"name_variants":[{"name":"Imran Talat","source":"filing","n_filings":7,"first_seen":"2023-11-09","last_seen":"2026-07-21"}],"transactions":[{"id":5938340,"accession":"0001869579-26-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001869579-26-000007","line_url":"/filing/0001869579-26-000007#line-1","is_derivative":false,"issuer_cik":"0001856725","issuer_name":"Rani Therapeutics Holdings, Inc.","issuer_ticker":"RANI","issuer_name_source":null,"issuer_url":"/issuer/0001856725","owner_cik":"0001869579","owner_name":"Imran Talat","owner_display_name":"Imran Talat","owner_url":"/insider/0001869579","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":35000.0,"shares_display":"35,000","price_per_share":0.7198,"price_display":"0.72","price_state":"stated","total_value":25193.0,"total_display":"25,193.00","total_whole":"25,193","shares_owned_after":469736.0,"shares_owned_after_display":"469,736","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-17","filed_date":"2026-07-21","scope":"insider"},{"id":5852593,"accession":"0001869579-26-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001869579-26-000006","line_url":"/filing/0001869579-26-000006#line-1","is_derivative":false,"issuer_cik":"0001856725","issuer_name":"Rani Therapeutics Holdings, Inc.","issuer_ticker":"RANI","issuer_name_source":null,"issuer_url":"/issuer/0001856725","owner_cik":"0001869579","owner_name":"Imran Talat","owner_display_name":"Imran Talat","owner_url":"/insider/0001869579","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8014.0,"shares_display":"8,014","price_per_share":1.41,"price_display":"1.41","price_state":"stated","total_value":11299.74,"total_display":"11,299.74","total_whole":"11,300","shares_owned_after":486737.0,"shares_owned_after_display":"486,737","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-27","filed_date":"2026-07-21","scope":"insider"},{"id":2350630,"accession":"0000950170-24-134828","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-134828","line_url":"/filing/0000950170-24-134828#line-1","is_derivative":false,"issuer_cik":"0001856725","issuer_name":"Rani Therapeutics Holdings, Inc.","issuer_ticker":"RANI","issuer_name_source":null,"issuer_url":"/issuer/0001856725","owner_cik":"0001869579","owner_name":"Imran Talat","owner_display_name":"Imran Talat","owner_url":"/insider/0001869579","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10296.0,"shares_display":"10,296","price_per_share":1.94,"price_display":"1.94","price_state":"stated","total_value":19974.24,"total_display":"19,974.24","total_whole":"19,974","shares_owned_after":494751.0,"shares_owned_after_display":"494,751","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-09","filed_date":"2024-12-10","scope":"insider"},{"id":8530852,"accession":"0000950170-23-068864","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-068864","line_url":"/filing/0000950170-23-068864#line-1","is_derivative":false,"issuer_cik":"0001856725","issuer_name":"Rani Therapeutics Holdings, Inc.","issuer_ticker":"RANI","issuer_name_source":null,"issuer_url":"/issuer/0001856725","owner_cik":"0001869579","owner_name":"Imran Talat","owner_display_name":"Imran Talat","owner_url":"/insider/0001869579","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":2.27,"price_display":"2.27","price_state":"stated","total_value":22700.0,"total_display":"22,700.00","total_whole":"22,700","shares_owned_after":484455.0,"shares_owned_after_display":"484,455","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-06","filed_date":"2023-12-07","scope":"insider"},{"id":8646311,"accession":"0000950170-23-068442","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-068442","line_url":"/filing/0000950170-23-068442#line-1","is_derivative":false,"issuer_cik":"0001856725","issuer_name":"Rani Therapeutics Holdings, Inc.","issuer_ticker":"RANI","issuer_name_source":null,"issuer_url":"/issuer/0001856725","owner_cik":"0001869579","owner_name":"Imran Talat","owner_display_name":"Imran Talat","owner_url":"/insider/0001869579","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":2.57,"price_display":"2.57","price_state":"stated","total_value":12850.0,"total_display":"12,850.00","total_whole":"12,850","shares_owned_after":474455.0,"shares_owned_after_display":"474,455","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-04","filed_date":"2023-12-06","scope":"insider"},{"id":7838680,"accession":"0000950170-23-067149","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-067149","line_url":"/filing/0000950170-23-067149#line-1","is_derivative":false,"issuer_cik":"0001856725","issuer_name":"Rani Therapeutics Holdings, Inc.","issuer_ticker":"RANI","issuer_name_source":null,"issuer_url":"/issuer/0001856725","owner_cik":"0001869579","owner_name":"Imran Talat","owner_display_name":"Imran Talat","owner_url":"/insider/0001869579","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":2.05,"price_display":"2.05","price_state":"stated","total_value":41000.0,"total_display":"41,000.00","total_whole":"41,000","shares_owned_after":469455.0,"shares_owned_after_display":"469,455","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-29","filed_date":"2023-12-01","scope":"insider"},{"id":8216801,"accession":"0000950170-23-062001","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-062001","line_url":"/filing/0000950170-23-062001","is_derivative":false,"issuer_cik":"0001856725","issuer_name":"Rani Therapeutics Holdings, Inc.","issuer_ticker":"RANI","issuer_name_source":null,"issuer_url":"/issuer/0001856725","owner_cik":"0001869579","owner_name":"Imran Talat","owner_display_name":"Imran Talat","owner_url":"/insider/0001869579","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.995,"price_display":"2.00","price_state":"stated","total_value":9975.0,"total_display":"9,975.00","total_whole":"9,975","shares_owned_after":449455.0,"shares_owned_after_display":"449,455","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-07","filed_date":"2023-11-09","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":7,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001856725","name":"Rani Therapeutics Holdings, Inc.","url":"/issuer/0001856725","role":"Director, Officer (Chief Executive Officer)","n_filings":7,"first_seen":"2023-11-09","last_seen":"2026-07-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001869579","retrieved_at":"2026-08-25T21:18:59+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}